Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Metabolon in diabetes research pact with UT Health Science Center
August 2008
SHARING OPTIONS:

RESEARCH TRIANGLE PARK, N.C.óDiagnostic and services company Metabolon Inc. has partnered with the University of Texas Health Science Center at San Antonio to discover and validate biochemical biomarkers reflective of insulin resistance and beta cell dysfunction, according to an agreement announced by the parties in July. Using its patented biochemical profiling platform, Metabolon will analyze samples from various studies conducted by the research team of Dr. Ralph A. DeFronzo, a leader in diabetes research, specifically addressing the major pathophysiological pathways that lead to the development of type 2 diabetes, including insulin resistance and pancreatic dysfunction.

The partnership is expected to help drive development of Metabolon's pre-diabetes diagnostic products as well as provide valuable data for insulin resistance and diabetes-related research. Financial terms of the agreement were not made available. DDN


 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.